Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.
Cohen C, Wohl D, Arribas JR, Henry K, Van Lunzen J, Bloch M, Towner W, Wilkins E, Ebrahimi R, Porter D, White K, Walker I, Chuck S, De-Oertel S, Fralich T. Cohen C, et al. Among authors: walker i. AIDS. 2014 Apr 24;28(7):989-97. doi: 10.1097/QAD.0000000000000169. AIDS. 2014. PMID: 24508782 Clinical Trial.
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S. Brunetta J, et al. Among authors: walker i. Patient. 2015 Jun;8(3):257-67. doi: 10.1007/s40271-015-0123-2. Patient. 2015. PMID: 25808940 Free PMC article. Clinical Trial.
Use of monoacetyl-4-hydroxyaminoquinoline 1-oxide to probe contacts between guanines and protein in the minor and major grooves of DNA. Interaction of Escherichia coli integration host factor with its recognition site in the early promoter and transposition enhancer of bacteriophage Mu.
Panigrahi GB, Walker IG. Panigrahi GB, et al. Among authors: walker ig. Biochemistry. 1991 Oct 8;30(40):9761-7. doi: 10.1021/bi00104a028. Biochemistry. 1991. PMID: 1832956
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
Radford M, Garcia-Horton A, Badami R, Jin E, Usmani N, Grafodatskaya D, McCready E, Khalaf D, Walker I, Leber B, Lepic K, Pond G, Berg T. Radford M, et al. Among authors: walker i. Transplant Cell Ther. 2024 Nov 14:S2666-6367(24)00759-0. doi: 10.1016/j.jtct.2024.11.006. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39547311 Free article.
890 results